Paclitaxel anti-cancer therapeutics: from discovery to clinical use.

Area of Science:

• Natural Products Chemistry
• Oncology
• Pharmacology

Background:

• Paclitaxel (PTX) is a crucial natural product from Taxus species with significant anti-cancer activity.
• PTX functions by interacting with tubulin, disrupting microtubule dynamics and inducing cancer cell death.
• Approved PTX derivatives offer low toxicity, high efficacy, and broad-spectrum applications.

Purpose of the Study:

• To review the challenges and advancements in Paclitaxel (PTX) production and delivery.
• To provide a comprehensive reference for PTX's rational development and utilization.
• To explore PTX's sourcing, properties, mechanisms, clinical trials, and chemo-immunotherapy.

Main Methods:

• Literature review of Paclitaxel (PTX) research.
• Analysis of PTX sourcing and production methods.
• Examination of PTX's physicochemical properties and anti-cancer mechanisms.

Main Results:

• Increased demand for PTX necessitates alternative production and enhanced delivery systems.
• Nanocarrier applications show promise for improving PTX bioavailability.
• Ongoing clinical trials and chemo-immunotherapy research expand PTX's therapeutic potential.

Conclusions:

• Addressing PTX accessibility challenges is crucial for its widespread clinical use.
• Advancements in PTX production and nanodelivery are vital for enhancing its therapeutic index.
• Continued research into PTX mechanisms and applications will optimize its role in cancer treatment.